300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Mobile
Consumer
Health Care
Energy
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
Biotechnology
Software
Renewable Energy
eSports
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Legal
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Music
Publishing
Mobile Apps
Wine and Spirits
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Art
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Real Estate
Sporting Goods
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Uzbekistan
Serbia
Saudi Arabia
New Zealand
Morocco
Australia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
Ireland
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Rwanda
Philippines
Portugal
El Salvador
Senegal
Sierra Leone
Tanzania
United States
India
Germany
Indonesia
Dominican Republic
Middle East
Bermuda
Asia
Albania
Argentina
Spain
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Bangladesh
Jordan
Azerbaijan
Ethiopia
Austria
Bulgaria
Faroe Islands
Ecuador
Jersey
Bolivia
Belize
Algeria
Bahrain
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Estonia
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Bahamas
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device VC Funds & Investors in China (October 2026)

The most active venture capital funds investing in China Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in China Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Qiming Venture Partners
VC Fund
29 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $4.3M–$120M
HSG
VC Fund
15 China, United States, Singapore Series A, Series B, Seed Artificial Intelligence, Software, Health Care $2M–$200M
Cowin Capital
VC Fund
14 China, United States, Hong Kong Series A, Series B, Seed Manufacturing, Health Care, Semiconductor $1.4M–$51M
IDG Capital
VC Fund
13 China, United States, Singapore Series A, Series B, Seed Internet, Software, E-Commerce $600k–$110M
Shunwei Capital
VC Fund
12 China, United States, India Series A, Series B, Seed Manufacturing, Software, Artificial Intelligence $1M–$74M
Lilly Asia Ventures
VC Fund
12 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$308M
BioVenture
VC Fund
12 China, United States, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Medical $4.4M–$85M
Taiyu Investment
VC Fund
12 China Seed, Series A, Angel Medical, Health Care, Biotechnology $434k–$100M
Addor Capital
VC Fund
11 China, Hong Kong, United States Series A, Series B, Venture - Series Unknown Manufacturing, Semiconductor, Electronics $1.4M–$145M
CD Capital
VC Fund
11 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Matrix Partners China
VC Fund
11 China, United States, Singapore Series A, Series B, Seed Health Care, Software, Biotechnology $1.2M–$137M
BioTrack Capital
VC Fund
10 China, United States, Singapore Series A, Series B, Seed Biotechnology, Health Care, Medical $14M–$168M
BIOCHING CAPITAL
VC Fund
10 China Angel, Series A, Seed Medical Device, Medical, Biotechnology $433k–$15M
Haibang Capital
VC Fund
9 China Series A, Series B, Angel Health Care, Biotechnology, Manufacturing $435k–$79M
ZhenFund
VC Fund
9 China, United States, Singapore Seed, Series A, Angel Artificial Intelligence, Software, E-Commerce $146k–$22M
Prox Ventures
VC Fund
9 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$30M
Northern Light Venture Capital
VC Fund
9 China, United States, South Korea Series A, Series B, Venture - Series Unknown Health Care, Medical, Biotechnology $1.5M–$60M
EFung Capital
VC Fund
9 China, United States, India Series A, Series B, Series C Health Care, Biotechnology, Medical $1.4M–$100M
Med-Fine Capital
VC Fund
8 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $3M–$60M
Dalton Venture
VC Fund
8 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $512k–$50M
Legend Capital
VC Fund
8 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.9M–$200M
Oriza Seed Capital (Oriza Yuandian)
VC Fund
8 China, United States, Singapore Series A, Seed, Angel Manufacturing, Health Care, Medical $223k–$60M
SND Ventures Group
VC Fund
7 China Series A, Series B, Seed Manufacturing, Semiconductor, Health Care $1.4M–$28M
Shenzhen Capital Group
VC Fund
7 China, United States, Japan Series A, Series B, Seed Manufacturing, Health Care, Software $1.4M–$141M
Huagai Capital
VC Fund
6 China, United States, Hong Kong Series A, Series B, Angel Health Care, Medical, Biotechnology $425k–$90M
Share Capital
VC Fund
6 China, United States, Colombia Series A, Series B, Seed Health Care, Medical, Biotechnology $161k–$93M
Oriza Holdings
VC Fund
6 China, United States, Canada Series A, Series B, Seed Manufacturing, Health Care, Biotechnology $1.5M–$100M
SZHTI Group
VC Fund
6 China, Canada, United States Series A, Angel, Series B Manufacturing, Electronics, Health Care $425k–$16M
Sunland Fund
VC Fund
6 China Series A, Series B, Seed Health Care, Medical, Medical Device $1.4M–$28M
Highlight Capital
VC Fund
6 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $3.1M–$84M
Fortune Venture Capital
VC Fund
6 China, Japan, United States Series A, Series B, Seed Manufacturing, Software, Information Technology $462k–$73M
Marathon Venture Partners
VC Fund
6 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $1.5M–$142M
Haiyuan Capital
VC Fund
6 China Series A, Seed, Angel Manufacturing, Medical, Semiconductor $432k–$15M
Frees Fund
VC Fund
5 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Health Care, Biotechnology $447k–$28M
CDH Investments
VC Fund
5 China, United States, Canada Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $3M–$220M
Huaige Capital
VC Fund
5 China Series A, Angel, Seed Medical, Health Care, Biotechnology $455k–$36M
Tsinghua Innovation Ventures
VC Fund
5 China Venture - Series Unknown, Series A, Seed Manufacturing, Medical, Health Care $832k–$23M
Apricot Capital
VC Fund
5 China, United States, Hong Kong Series A, Seed, Series B Health Care, Biotechnology, Medical $3M–$90M
Legend Star
VC Fund
5 China, United States, France Series A, Seed, Angel Health Care, Medical, Robotics $425k–$52M
Volcanics Venture
VC Fund
4 China, United States, Hong Kong Series A, Series B, Seed Health Care, Artificial Intelligence, Biotechnology $350k–$60M
CMB International Capital Corporation
VC Fund
4 China, United States, Japan Series A, Series B, Series C Manufacturing, Biotechnology, Health Care $13M–$250M
Qiaojing Capital
VC Fund
4 China Series A, Series B, Post-IPO Equity Health Care, Medical, Medical Device $1.4M–$40M
Tasly Capital
VC Fund
4 China Series A, Series B, Seed Medical, Biotechnology, Health Care $14M–$42M
Insight Capital
VC Fund
4 China, Thailand, United Kingdom Series A, Seed, Series B Health Care, Medical, Medical Device $2.9M–$65M
HY Capital
VC Fund
4 China, United States Series A, Seed, Series B Health Care, Medical, Medical Device $83k–$28M
Korea Investment Partners
VC Fund
4 South Korea, United States, China Series A, Series B, Seed Biotechnology, Health Care, Information Technology $973k–$50M
ASBV
VC Fund
4 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $471k–$34M
GSR United Capital
VC Fund
4 China, United States, Singapore Series A, Series B, Seed Manufacturing, Robotics, Automotive $450k–$50M
Luminous Ventures (former Lightspeed China Partners)
VC Fund
4 China, Singapore, United States Series A, Series B, Seed Manufacturing, Internet, Robotics $3M–$110M
Green Pine Capital Partners
VC Fund
4 China, United States, Canada Series A, Angel, Series B Artificial Intelligence, Biotechnology, Manufacturing $425k–$150M
Access all 1621 VC funds in China Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 29 investments in China Medical Device startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 1195
  • Round size: Series A $4.3M–$48M; Series B $7.9M–$90M; Series C $12M–$120M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely actively investing — fresh fund, raised $8M in 2026

Portfolio highlights

  • LP Amina — LP Amina focuses on products that improve coal-fired power plant's emissions and efficiency. Leveraging 50 unique patented products to improve the firing system of a coal-fired boiler, including Rotating Vane Wheels, High Performance Classifiers, Coal Pipe Balancing Technologies, and Burner Enhancements, the Company provides products andsolutions that will meet or exceed the expectations of their customers. Furthermore, LP Amina's corporate culture is one of a relentless pursuit of continuous improvement. Utilizing the latest technology and traditional know-how from the World's two largest users of Coal for power generation, the Company is well positioned to develop new products and solutions to meet the ever changing needs of Power Industry.LP Amina's staff has over 20 years of experience in the design, fabrication, installation and commissioning of coal-fired power plants. During this time, the team has gained a wide range of experience from the evolution of the US Power Market. Increases in environmental regulations and free market driven energy prices have forced plant operators to reduce emissions and improve reliability while lowering operational cost. LP Amina's engineering and design team will leverage this experience gained from the US and Europe to address the emergence of similar issues in China.
  • Nice Tuan — Nice Tuan is an e-commerce platform that provides daily groceries and miscellaneous products.
  • Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Show all investments...

HSG
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 15 investments in China Medical Device startups

HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 1085
  • Round size: Seed $2M–$50M; Series A $4M–$100M; Series B $11M–$200M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $2.5B in 2024

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Show all investments...

Cowin Capital
VC Fund · Shenzhen, Guangdong, China · 14 investments in China Medical Device startups

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Semiconductor
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 366
  • Round size: Seed $1.4M–$20M; Series A $2.8M–$51M; Series B $7.2M–$44M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — raised $75M in 2014

Portfolio highlights

  • Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
  • Digital China — Digital China is a robotics company focused on developing humanoid interactive robots that can break traditional boundaries and create emotionally resonated partners.
  • Loxun Kuangteng — Longxun Kuangteng injects computing technology, simulation methods, and mathematical algorithms into powerful material simulation tools to help researchers. They develop a software and hardware integration solution to provide customers with a range of services and support. They also provide customers with training, cooperation meetings, and otherservices.
Show all investments...

IDG Capital
VC Fund · Beijing, Beijing, China · 13 investments in China Medical Device startups, 70 in the past 12 months

IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support.

Show more...

Investment focus

  • Industry: Internet, Software, E-Commerce
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 1220
  • Round size: Seed $600k–$44M; Series A $2M–$100M; Series B $6.2M–$110M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Naive.ai — Naive.ai is a startup specializing in training AI agents with open-source models. It emphasizes post-training of open-source models to develop advanced AI agents.
  • Arrow Yuan Technology — Arrow Yuan Technology focuses on the research and development of reusable stainless steel propellant tanks.
  • Apex Intelligence — Apex Intelligence develops self-evolving AI models for scientific discovery.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 12 investments in China Medical Device startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, India

Investor stats

  • Total investments: 616
  • Round size: Seed $1M–$74M; Series A $1.5M–$41M; Series B $8.2M–$55M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • Sleptay — Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous system diseases.
  • Baiyue Interlink — Baiyue Interlink is a commercial aerospace company capable of reusable Level 1 and Level 2 space transportation.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 12 investments in China Medical Device startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 253
  • Round size: Series A $14M–$100M; Series B $25M–$110M; Series C $30M–$308M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
  • NeuShen Therapeutics — We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
  • Connexus Therapeutics — Connexus Therapeutics is a private, venture-backed biotechnology startup.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 12 investments in China Medical Device startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 192
  • Round size: Seed $7.9M–$41M; Series A $4.4M–$47M; Series B $7.1M–$85M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $204M in 2016

Portfolio highlights

  • Inno Medicine — Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Taiyu Investment
VC Fund · 12 investments in China Medical Device startups, 9 in the past 12 months

Taiyu Investment is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China

Investor stats

  • Total investments: 49
  • Round size: Seed $2.8M–$20M; Angel $434k–$100M; Series A $13M–$29M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Immunocan — Immunocan focuses on the development of fully human antibody animals, artificial chromosome carriers with independent intellectual property rights, focusing on tumor treatment, and developing antibody therapeutic drugs.
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Infineon Multiomics — Infineon Multiomics is a biotechnology company that provides research and application of space multiomics technology.
Show all investments...

Addor Capital
VC Fund · Nanjing, Jiangsu, China · 11 investments in China Medical Device startups

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Electronics
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 363
  • Round size: Series A $1.6M–$30M; Series B $12M–$145M; Venture - Series Unknown $1.4M–$101M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $241M in 2021

Portfolio highlights

  • Ibeki — Ibeki provides tiny photoelectric displacement sensors and servo control systems. eBridge uses the high precision and miniaturization of its precision motion drive technology to provide customers with a more complete technology portfolio, and has successfully transformed its core technology into a number of military and civilian products,particularly in aerospace, medical equipment, and intelligent control.
  • Deep Blue Aerospace — Deep Blue Aerospace is a commercial carrier rocket developer.
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 11 investments in China Medical Device startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 73
  • Round size: Seed $1.4M–$15M; Series A $1.5M–$32M; Series B $7.6M–$34M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
  • Pipi Bear — Pipi Bear is a creator of living robots and health goods, with a focus on those that improve the lives of the elderly.
  • CORE Biomedicine — CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Matrix Partners China
VC Fund · Beijing, Beijing, China · 11 investments in China Medical Device startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 706
  • Round size: Seed $1.2M–$74M; Series A $2.9M–$52M; Series B $10M–$137M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $92M in 2023

Portfolio highlights

  • Camera360 — Camera360 is a professional but easy-to use App for photo editing and selfie retouching. Tag #camera360
  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
Show all investments...

BioTrack Capital
VC Fund · Shanghai, Shanghai, China · 10 investments in China Medical Device startups, 19 in the past 12 months

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 94
  • Round size: Seed $15M–$168M; Series A $14M–$45M; Series B $15M–$147M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Taiyi Quantum — Taiyi Quantum is dedicated to encouraging innovation in the distribution and implementation of quantum computing technology, as well as developing sophisticated quantum algorithms and delivering tailored computing solutions for businesses and research institutes.
  • Convergen — Convergen develops TrimTAC, a targeted protein degradation platform for treating neurodegenerative diseases and other conditions driven by protein aggregates
  • Zhiyue Space Intelligence — Zhiyue Space Intelligence specializes in robotic brain and brain systems.
Show all investments...

BIOCHING CAPITAL
VC Fund · Longgang, Guangdong, China · 10 investments in China Medical Device startups

BIOCHING CAPITAL is an investment management firm.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Biotechnology
  • Stage:Angel, Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 22
  • Round size: Angel $433k–$15M; Series A $14M–$14M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Lunke Medical — Lunke Medical focuses on the research, development, production, and sales of medical devices, with particular strength and expertise in high-pressure technologies. The company is committed to delivering safe, reliable, and innovative solutions by combining advanced engineering, strict quality control, and continuous technological advancement tomeet the evolving needs of the medical industry.
  • Rittal Medical — Rittal Medical is a reputable, large-scale Chinese manufacturer of animal imaging equipment with an emphasis on research, development, and production.
  • Moer New Materials — Moer New Materials provides filtering membranes for the biopharmaceutical and semiconductor sectors.
Show all investments...

Haibang Capital
VC Fund · Hangzhou, Zhejiang, China · 9 investments in China Medical Device startups, 7 in the past 12 months

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Angel
  • Geography: China

Investor stats

  • Total investments: 50
  • Round size: Angel $435k–$2.8M; Series A $1.5M–$15M; Series B $10M–$79M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • MatriQ —
  • Hopstem — Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
  • Hongde New Materials — Hongde New Materials produces thermoplastic composite materials with fiber reinforcement. It offers energy storage and auxiliary components for solar and automobile power and steering systems.
Show all investments...

ZhenFund
VC Fund · Beijing, Beijing, China · 9 investments in China Medical Device startups

ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 751
  • Round size: Seed $146k–$14M; Angel $425k–$3M; Series A $873k–$22M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely still investing — raised $140M in 2022

Portfolio highlights

  • Snowplus — SNOWPLUS is an e-cigarette brand that provides users with e-cigarette products through a combination of online and offline sales models. The products are available in 12 different types of flavors. The products use TrueFeel honeycomb ceramic atomization technology and Aeroflow intake. Technology; In addition to reference to the existing food-gradestandards in China, Xuejia has also passed a number of third-party certifications in terms of safety. The core components such as atomizing core and cigarette holder comply with the highest medical safety standards of the FDA and the European Union.
  • Futuring Robot — Futuring Robot is a developer of dual-arm home service robots focusing on C-end home scenarios.
  • Qisuan Kuang-Chi — Qisuan Kuang-Chi is a pioneering artificial intelligence hardware company focusing on the research, development, and engineering of AI optical computing chips and related system infrastructure. The company utilizes a proprietary all-optical interference technology architecture to bypass physical constraints found in legacy electronic chipsets,aiming to establish computational infrastructure for Artificial General Intelligence (AGI).
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 9 investments in China Medical Device startups, 6 in the past 12 months

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 83
  • Round size: Seed $2.5M–$30M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 9 investments in China Medical Device startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 397
  • Round size: Series A $2.9M–$40M; Series B $8.8M–$56M; Venture - Series Unknown $1.5M–$60M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 9 investments in China Medical Device startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 85
  • Round size: Series A $1.4M–$36M; Series B $14M–$100M; Series C $14M–$74M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Xinyun Life — Xinyun Life Sciences is a high tech medical enterprise focusing on the R&D and industrialization of artificial intelligence vascular intervention devices. The company integrates AI deeply into its hardware development using a unique dual closed- oop system.
  • Glimmer Gene — Glimmer Gene develops a comprehensive gene editing and epigenetic toolkit with independent intellectual property rights.
  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 8 investments in China Medical Device startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 83
  • Round size: Seed $8M–$60M; Series A $3M–$40M; Series B $12M–$60M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2019

Portfolio highlights

  • Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
  • Tianyikang Biotechnology — Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.
  • Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 8 investments in China Medical Device startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 143
  • Round size: Seed $512k–$5M; Series A $3M–$17M; Series B $3.2M–$50M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Vibronix — Vibronix innovates for Precision Healthcare with spectroscopic imaging, optical & acoustic sensing, and machine learning.
  • PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Legend Capital
VC Fund · Beijing, Beijing, China · 8 investments in China Medical Device startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 518
  • Round size: Series A $2.9M–$93M; Series B $12M–$100M; Series C $15M–$200M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • Huixin Bio — Huixin Bio is a developer of exosome purification products and early cancer detection technology.
  • Honghu Future Energy — Honghu Fusion is a commercial nuclear fusion startup developing high-temperature superconducting stellarator technology
Show all investments...

Oriza Seed Capital (Oriza Yuandian)
VC Fund · Suzhou, Jiangsu, China · 8 investments in China Medical Device startups, 34 in the past 12 months

Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Medical
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 153
  • Round size: Seed $223k–$25M; Angel $425k–$15M; Series A $1.4M–$60M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Diver Innovation — Diver Innovation centers on intelligent cross-medium unmanned aerial vehicles.
  • Navi Therapeutics — Navi Therapeutics is a biotechnology company focused on developing next-generation antibody-drug conjugates and antibody-based therapeutics for oncology
  • Thortime Technology — Thortime Technology is a hard-tech company specializing in the full-stack development, manufacturing, and delivery of Neutral Beam Injection systems for controllable nuclear fusion devices.
Show all investments...

SND Ventures Group
VC Fund · Suzhou, Jiangsu, China · 7 investments in China Medical Device startups, 8 in the past 12 months

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 84
  • Round size: Series A $1.6M–$21M; Series B $1.4M–$28M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Ruiqi Deep Space — Ruichi Deep Space is an intelligent remote sensing constellation company built on space-based capabilities and driven by AI , aiming to construct a " commercial aerospace" platform.
  • Jipai Electromagnetic — Jipai Electromagnetic specializes in the manufacture of automobile components and accessories.
  • Sicui Thermal Control — Sicui Thermal Control focuses on the design of next-generation semiconductor and microelectronics thermal management solutions.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 7 investments in China Medical Device startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 645
  • Round size: Seed $1.4M–$29M; Series A $1.6M–$122M; Series B $4.9M–$141M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Prosemi — Pusenmei is a precision micro-resistance current sensor developer company committed to delivering professional and diverse precision micro-resistance current detecting resistors and circuit protection solutions.
  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Waker Biology — Weike Bio is a gene therapy drug development company.
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 6 investments in China Medical Device startups, 10 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 153
  • Round size: Angel $425k–$15M; Series A $1.5M–$73M; Series B $8.5M–$90M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • SeaArt — SeaArt AI is an all-in-one AI creativity community for art, videos, audio, and AI chats, where creators collaborate, spark inspiration, and grow together.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • GigaAI — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Show all investments...

Share Capital
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Colombia

Investor stats

  • Total investments: 112
  • Round size: Seed $161k–$7.3M; Series A $1.4M–$18M; Series B $2.9M–$93M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • SuperDimension Power — SuperDimension is dedicated to creating leading embodied intelligent brains and robot bodies.
  • Help Therapeutics — Help Stem Cell Innovations Co. Ltd. is the first biotechnology company in China to use iPSC-induced pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. Relying on this core technology, Elp Regenerative Medicine is committed to building a national biological sample bank and cell preparation center,leading the frontier of cell therapy, promoting the clinical transformation of regenerative medicine, and solving the clinically unresolvable degenerative and functional impairment diseases. Reshape human health.
Show all investments...

Oriza Holdings
VC Fund · Suzhou, Jiangsu, China · 6 investments in China Medical Device startups, 35 in the past 12 months

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 224
  • Round size: Seed $4.5M–$30M; Series A $1.5M–$46M; Series B $10M–$100M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.
  • Toto Technology — Borg Technology is a producer of testing and micromachining tools, with an emphasis on optical and precision optical devices.
Show all investments...

SZHTI Group
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups, 15 in the past 12 months

SZHTI Group is a company that provides asset management and financing services.

Show more...

Investment focus

  • Industry: Manufacturing, Electronics, Health Care
  • Stage:Series A, Angel, Series B
  • Geography: China, Canada, United States

Investor stats

  • Total investments: 137
  • Round size: Angel $425k–$1.4M; Series A $888k–$16M; Series B $3.2M–$15M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • GeneMind Biosciences — GeneMind Biosciences is a domestic third-generation single-molecule gene sequencing system. GeneMind Biosciences has been fighting to provide better gene sequencing solutions for clinicians and researchers. A Gene sequencer is the crown jewel in the field of gene sequencing. Entrepreneurs will lead their innovations and breakthroughs throughunremitting research and exploration. GeneMind believes that the strong pass of the difficulty is like a wall of iron, yet with firm strides, we are conquering its summit.
  • Kiri Innovation — KIRI Innovation develops affordable and innovative 3D scanners. Phiz 3D Scanner is a low cost, high precision laser 3D scanner that works with smartphones. Using today's phone camera and powerful CPU, a laser 3D scanner has never been so affordable and smart.
  • Xinhe Robot Technology — Xinhe Robot Technology is an autonomous grain storage robotics manufacturer automating depot leveling and monitoring tasks.
Show all investments...

Sunland Fund
VC Fund · Shanghai, Shanghai, China · 6 investments in China Medical Device startups

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 35
  • Round size: Seed $1.4M–$14M; Series A $1.6M–$16M; Series B $1.5M–$28M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
  • Insight Technology — Insight Technology is an instrument manufacturer and seller company that specializes in instrument sales, intelligent instrument sales, mechanical equipment research and development, and more.
  • Yangshan Medical Technology — Yangshan Medical Technology is a Shanghai-based company specializing in dental surgery robots.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 6 investments in China Medical Device startups, 33 in the past 12 months

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 179
  • Round size: Seed $10M–$84M; Series A $3.1M–$73M; Series B $7.6M–$70M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Genuine Rhythm — Genuine Rhythm is an innovative AI Agent technology developer specializing in bespoke agent creation, advanced algorithm R&D, and rigorous security compliance solutions tailored to diverse enterprise needs.
  • Ziwei Technology — Ziwei Technology is a high-tech company making returnable spacecraft.
  • Differential Robotics — Differential Robotics is a robotics company providing research, design, and development of aerial robots and intelligent autonomous drones.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Fortune Venture Capital
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, Japan, United States

Investor stats

  • Total investments: 324
  • Round size: Seed $462k–$73M; Series A $1.5M–$70M; Series B $3M–$60M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $860M in 2021

Portfolio highlights

  • Sandstone — SandStone is a product, solution and service provider focused on next-generation data storage (ServerSAN), which is dedicated to helping users cope with data storage, traffic and data management complexity, helping users build storage virtualization and Computation of virtualization as the core cloud computing infrastructure environment, andgradually provide data processing, mining, analysis and intelligence in the field of big data professional systems and services.
  • Sungen Biomedical — Sungen Biomedical is an innovative antibody drug R&D enterprise. It has established international standard technology platforms and original biological macromolecular R&D pipelines. Their focus includes therapeutic drugs for cardiovascular and cerebrovascular diseases, tumors, and more.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

Marathon Venture Partners
VC Fund · Shanghai, Shanghai, China · 6 investments in China Medical Device startups

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 63
  • Round size: Seed $7M–$13M; Series A $1.5M–$29M; Series B $14M–$142M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Fungifuture — Fungifuture is a synthetic biomaterials company specializing in the research and development and production of fungal fiber materials.
  • Ruize Health — Ruize Health is a commercial insurance company that focuses on health consumption and commercial insurance.
  • Fuxin Technology Innovation — Fuxin Kechuang is a high-tech company that specializes in offering detailed information solutions for the medical and healthcare industries. The business offers creative software solutions and services to a range of healthcare organizations, actively supports the digital transformation of healthcare, and uplifts the medical sector. The company hasgained recognition and has become a partner of big and medium-sized medical institutions and healthcare institutions by relying on its technological research and development power, service capabilities, and ecosystem of medical and health software.
Show all investments...

Haiyuan Capital
VC Fund · Shenzhen, Guangdong, China · 6 investments in China Medical Device startups

Goldport Capital is a Shenzhen-based asset management company.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Semiconductor
  • Stage:Series A, Seed, Angel
  • Geography: China

Investor stats

  • Total investments: 79
  • Round size: Seed $1.4M–$15M; Angel $432k–$14M; Series A $1.4M–$15M
  • Lead/follow: 56% lead, 44% follow

Portfolio highlights

  • Anxin Medical — Anxin Medical is a company dedicated to the research, development, production, and sales of innovative medical devices. The company focuses on advancing healthcare technology through continuous innovation, integrating cutting-edge science and engineering to create high-quality, reliable, and efficient medical products.
  • Deep Carbon Source — Senge Carbon Source makes advanced porous carbon for energy storage devices.
  • Feat-Aero Intelligent Technologies — Feat-Aero is a high tech firm designing digital assembly robots and smart tools for aerospace leaders like COMAC and AVIC.
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 5 investments in China Medical Device startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 243
  • Round size: Seed $1.4M–$14M; Angel $447k–$10M; Series A $1.6M–$28M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $144M in 2015

Portfolio highlights

  • Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
  • Flysound — Flysound is a hearing technology company focused on making advanced AI-powered hearing aids affordable and accessible. Its products combine AI sound processing, Bluetooth connectivity, app-based personalization, and rechargeable convenience. With a focus on innovation, quality, and user-friendly design, Flysound aims to help people hear moreclearly and stay connected to everyday life.
  • Yanming Biology — Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Show all investments...

CDH Investments
VC Fund · Kowloon City, Kowloon, Hong Kong · 5 investments in China Medical Device startups, 42 in the past 12 months

CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 329
  • Round size: Series A $3M–$100M; Series B $14M–$141M; Series C $30M–$220M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Synapath — Synapath focuses on using embodied intelligence and robotics technology to create clever systems for making decisions for multi-domain applications that are intelligent.
  • Dingxi Zhichuang — Dingxi Zhichuang is an integrated circuit chip developer specializing in the manufacture, design, and services of integrated circuit chips and products, as well as sales and the manufacturing of semiconductor device special equipment.
  • Deep Space Matrix Technology — Deep Space Matrix Technology's long-term objective is to benchmark against SpaceX and progressively construct a Chinese equivalent of an integrated air, space, and sea superintelligent system.
Show all investments...

Huaige Capital
VC Fund · Shanghai, Shanghai, China · 5 investments in China Medical Device startups

Huaige Capital is a venture capital focusing on healthcare sector.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Angel, Seed
  • Geography: China

Investor stats

  • Total investments: 23
  • Round size: Angel $455k–$14M; Series A $3M–$36M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Heerkang — Heerkang is a medical technology company that provides medical device research and sales, and health consultation services.
  • Xianyan Biopharma — Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Show all investments...

Tsinghua Innovation Ventures
VC Fund · Haidian, Beijing, China · 5 investments in China Medical Device startups, 15 in the past 12 months

Tsinghua Innovation Ventures is an investment management firm.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: China

Investor stats

  • Total investments: 97
  • Round size: Seed $832k–$15M; Series A $1.6M–$23M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
  • Brighten Data — Brighten Data is an AI-native platform that provides one-stop AI data intelligence products and large model application services.
  • FangQing Technology — Fangqing Technology is a company mainly engaged in multiple areas of the communications equipment and software industry. Its core business activities include software development and sales, software outsourcing services, information system integration services, and computer system services.
Show all investments...

Apricot Capital
VC Fund · Shanghai, Shanghai, China · 5 investments in China Medical Device startups, 14 in the past 12 months

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 47
  • Round size: Seed $10M–$41M; Series A $3M–$54M; Series B $14M–$90M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely actively investing — fresh fund, raised $41M in 2025

Portfolio highlights

  • iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
  • Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
  • Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Show all investments...

Legend Star
VC Fund · Beijing, Beijing, China · 5 investments in China Medical Device startups, 16 in the past 12 months

Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies.

Show more...

Investment focus

  • Industry: Health Care, Medical, Robotics
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, France

Investor stats

  • Total investments: 172
  • Round size: Seed $1.5M–$19M; Angel $425k–$7.8M; Series A $1.5M–$52M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — raised $127M in 2018

Portfolio highlights

  • CellWall — Cellwall is a desktop robot developer focused on the research, development, upgrade, and marketing of its initial product, CyboPal ONE.
  • Ubot Robotics — Ubot Robotics is dedicated to developing leg-and-foot bionic robots and has built a diverse range of bipedal, quadrupedal, hexapodal, and other leg-and-foot bionic robots.
  • Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Show all investments...

Volcanics Venture
VC Fund · Changning, Shanghai, China · 4 investments in China Medical Device startups

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 105
  • Round size: Seed $350k–$17M; Series A $1.4M–$22M; Series B $6.7M–$60M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2018

Portfolio highlights

  • Unisic — Unisic designs and manufactures silicon carbide core power components. Unisic develops sets of products based on silicon carbide and has applied silicon carbide power modules to aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, data centers, and other important fields.
  • EVAS Intelligence — EVAS Intelligence is an autonomous driving chip startup. The company was founded by Liu Hui.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
CMB International Capital Corporation
VC Fund · Central, Hong Kong Island, Hong Kong · 4 investments in China Medical Device startups, 25 in the past 12 months

CMB International Capital Corporation is an investment banking firm that offers comprehensive professional services and financial advisory services. It provides mergers and acquisitions, initial public offering, equity underwriting, company restructuring, project financing, and business consulting services. CMB International Capital Corporationprovides corporate finance, asset management, wealth management and securities brokerage services. Additionally, it offers debt financing and transaction advisory services, placement of shares and refinancing for listed companies. CMB International Capital Corporation’s clientele include institutional, corporate and individual customers both domestic and overseas. It began operation in 1987, with its headquarters in Central in Hong Kong as a subsidiary of China Merchants Bank.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 149
  • Round size: Series A $13M–$142M; Series B $15M–$224M; Series C $35M–$250M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Zhongke lon — Zhongke lon engages in manufacturing high-end medical devices such as proton therapy equipment.
  • Megawave Fusion — Megawave Fusion focuses on high-power radio frequency transmitters, high-voltage power supplies.
  • Raysolve — Founded in 2019, Raysolve is dedicated to the R&D of Micro-LED micro-display technology, in particular chip architecture, fabrication processes and the development of single-chip, full-color technology. The core team stemmed from the Hong Kong University of Science and Technology (HKUST) with decades of experience in the design andmanufacturing of cutting-edge microchips. The team announced the world’s first single-chip full-color Micro-LED micro-display in Silicon Valley in 2019.
Show all investments...

Qiaojing Capital
VC Fund · Shanghai, Shanghai, China · 4 investments in China Medical Device startups

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Series B, Post-IPO Equity
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Series A $1.4M–$40M; Series B $3M–$15M; Post-IPO Equity $1.5M–$38M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
  • Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
  • Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Show all investments...

Tasly Capital
VC Fund · Tianjin, Guangdong, China · 4 investments in China Medical Device startups

Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China

Investor stats

  • Total investments: 17
  • Round size: Series A $14M–$28M; Series B $15M–$42M
  • Lead/follow: 53% lead, 47% follow

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Bite Micro — Better Micro Medical is a medical device company that is characterized by intervention and non-implantation, and offers doctors with comprehensive solutions in the field of peripheral vascular and structural heart disease.
  • Hopstem — Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Show all investments...

Insight Capital
VC Fund · Beijing, Beijing, China · 4 investments in China Medical Device startups

Insight Capital is a venture capital firm focused on early-stage investment.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: China, Thailand, United Kingdom

Investor stats

  • Total investments: 28
  • Round size: Seed $14M–$15M; Series A $2.9M–$30M; Series B $15M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $72M in 2018

Portfolio highlights

  • MyInnoPharma — MyInnoPharma is a research and development company focusing on differentiated small molecule new drugs.
  • Rigato Medical Technology — Rigato Medical Technology focuses on the R&D and production of medical devices and supplies.
  • Hangzhou Dasheng Technology — Hangzhou Dasheng is a high-tech enterprise specializing in the research and development of medical surgical robot systems, dedicated to advancing precision medicine through innovative technologies, integrating artificial intelligence, robotics, and minimally invasive surgical solutions to improve clinical outcomes, enhance surgeon capabilities, andprovide safer, more efficient healthcare services worldwide.
Show all investments...

HY Capital
VC Fund · Changning, Shanghai, China · 4 investments in China Medical Device startups

HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 21
  • Round size: Seed $83k–$14M; Series A $199k–$16M; Series B $14M–$28M
  • Lead/follow: 52% lead, 48% follow

Portfolio highlights

  • Only Sanbio — Only Sanbio is a synthetic biotechnology company integrating R&D, production, and sales. Itsmed vision is to focus on the field of great health and great beauty, based on synthetic biology technology
  • Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
  • Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Show all investments...

Korea Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 4 investments in China Medical Device startups

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 538
  • Round size: Seed $973k–$10M; Series A $2.2M–$19M; Series B $4.9M–$50M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $60M in 2023

Portfolio highlights

  • Zamface — Zamface is an app that makes beauty video.
  • Wakebunny — Wakebunny is a company that specializes in IP-based commerce, leveraging intellectual property to create, market, and monetize unique products and experiences. By focusing on the strategic use of copyrights, trademarks, and brand assets, Wakebunny transforms original ideas, characters, and stories into commercially viable offerings across variousplatforms such as e-commerce, digital media, merchandising, and licensing.
  • Inovio Pharmaceuticals — INOVIO is advancing novel immunotherapy technologies to reshape the future of treating and preventing infectious diseases and cancer.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Medical Device startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 28
  • Round size: Seed $3M–$14M; Angel $471k–$485k; Series A $1.4M–$34M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

GSR United Capital
VC Fund · Beijing, Beijing, China · 4 investments in China Medical Device startups

"Founded in 2009, GSR United Capital focuses on equity investment in high-tech industries, focusing on investment and M&A opportunities in advanced manufacturing, next-generation information technology, industrial Internet/digital enterprise services and other fields. GSR United Capital manages both RMB master funds and industrialfunds established with local governments. Since its establishment, GSR United Capital has received strong support from China's top market-oriented mother fund, government-guided fund, wealth management institutions, global 500 enterprises, listed companies and other institutions. Among them, investors with state capital background include Guochuang Yuanhe, Guochuang Kaiyuan, SDIC Unity Capital, China Merchants Venture, Suzhou Fund, Nanchang Industrial Control, Weifang Financial Holding Group, Dongguan Dongcheng, Zhangjiagang Jincheng Investment & Development Co., ltd, etc. Suzhou GSL Venture Capital Management Company, founded in 2011, is a private equity fund manager of the comprehensive fund of GSR United Capital (referred to as "" GSR United Capital ""), and completed the registration of private equity fund manager on May 20, 2014, with the serial number P1002246.""A+ stage is the main stage, the middle and late stage is the auxiliary"" The company focuses on equity investment in high-tech industry, focusing on the strategy of ""A+"" stage, with a capital allocation ratio of 60%. The project in this stage is between ""engineering"" and ""scale commercialization"", which is the ideal range of ""bargaining power"" and can win a high proportion of relative returns. At the same time, 40% of the project will be allocated in the middle and late stages. The middle and late stages refer to enterprises with IPO expectations within 2-3 years, and the investment will be completed within 60 months in the early stage of the fund investment period (exit will start in the third and fourth years), which will be used as the basic plate for anchoring returns.GSR United Capital has invested in more than 100 high-tech start-ups, including Great Wisdom Software (financial information terminal, 601519), eCARBON (high thermal conductivity graphite heat dissipation material, 603133), TZTEK (Precision, 688003), METRON (Diamond wire material, 603133) 300861), GTEP (sludge treatment and recycling, has started the board meeting), Niu (electric two-wheeler, NASDAQ: NIU), LATTICELIGHTING (LED silicon substrate technology and application), Freetech (unmanned driving), Marknum Technology (big data), xMate (light collaborative robot), TAGEIDRIVER (autonomous driving), HUIRUI (high-precision metal 3D printing), DYSO (CNC machine tool parts), NEWLINK GROUP (energy Internet), and many cross-border enterprises Industries such as LianLian (online payment), Xingyun Group (cross-border supply chain), Tec-Do (outbound brand digital marketing, Guangzhou), LAVA (smart guitar, Guangzhou), Shoplazza (outbound SaaS independent site construction tools, Guangzhou), E-ports (Internet for shipping industry), Chenhaiyun (sea-going compliance), Whalehouse.tech (intelligent warehousing), Huoyan (ABM intelligent marketing), Giiso (intelligent writing) and other excellent projects, which have won excess investment returns and social reputation. At present, the withdrawn projects include Great Wisdom Software (Financial information terminal, 601519), which has been fully withdrawn through listing, with return multiple reaching 8.96x, invested by GSR United Capital Phase I; TZTEK (Precision Measurement, 688003.STAR), fully exited through listing with return multiple reaching 2.74x, invested by GSR United Phase II and Botong Jinshi; eCARBON (high thermal conductivity graphite heat dissipation material, 603133), through the listing of all exit, return multiple reached 5x, invested by GSR United Capital Phase I Institute; METRON (Diamond Wire Materials, 300861), which was partially exited through listing with a return multiple of 4.5X and was invested by GSR United Phase III and Botong Jinshi Institute; Lebo Technology (cross-platform screen investment tool), partially exited through equity transfer, with a return multiple of 4.35x, invested by Botong Jinshi. Giiso (Intelligent Collaboration), which was partially withdrawn through equity transfer with a return multiple of 4.35x, was invested by Botong Jinshi.Zerowaste Asia Pte Ltd (ZA) was invested by Hongcheng RMB Fund, a subsidiary of GSR United Capital, in January 2017. It is committed to developing, producing and selling leading additives for heavy metal treatment. Its products have the characteristics of simple process, high efficiency, safety and environmental protection, and low cost. The company's valuation has grown from $58 million at the time of the investment to $142 million.Since February 2020, GSR United Capital has made more than 30 investments in the main fund. For example, it invested in Yuejing Technology (audio and video collaborative production tool) in February 2021, and the current multiple has reached 3.14 times. In September 2020, it invested in ZHICHUBAO.COM (procurement management SaaS platform), and the current multiple has reached 2.82 times. In April 2020, it invested in Starsee Intelligence (AI enabled military defense), and the current multiple has reached 2.81 times. Nahuo Technology Co., Ltd. received a subsequent round of investment from IDG, ZHICHUBAO.COM received a subsequent round of investment from Shunwei Capital, and Boqing Technology received a subsequent round of investment from KeyTone Ventures and Leaguer Capital."

Show more...

Investment focus

  • Industry: Manufacturing, Robotics, Automotive
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 212
  • Round size: Seed $450k–$14M; Series A $794k–$20M; Series B $789k–$50M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fresh fund, raised $69M in 2025

Portfolio highlights

  • Tec-do — 1.Tec-Do 2.0 is a leading AI martech company delivering result-centric marketing solutions for global business growth.
  • PhotoG — PhotoG is an international GenAI content marketing tool supplier. It operates in the fields of overseas content marketing and generative AI, with a focus on visual content development and e-commerce brand marketing.
  • Dewu Additive — Dewu Additive is a high-tech company at the forefront of 3D printing innovation, specializing in developing cutting-edge additive manufacturing solutions. The company focuses on creating advanced 3D printing technologies and materials for a wide range of industries, including aerospace, automotive, healthcare, and manufacturing.
Show all investments...

Luminous Ventures (former Lightspeed China Partners)
VC Fund · Shanghai, Shanghai, China · 4 investments in China Medical Device startups

Lightspeed China Partners was founded in 2011 as an independent venture capital group and began operating as Luminous Ventures in November 2025. Luminous Ventures is a leading venture capital firm serving entrepreneurs as a lead investor in early stage and emerging growth companies. It has offices in Shanghai,Beijing and Hong Kong.

Show more...

Investment focus

  • Industry: Manufacturing, Internet, Robotics
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, United States

Investor stats

  • Total investments: 196
  • Round size: Seed $4M–$28M; Series A $3M–$86M; Series B $10M–$110M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fresh fund, raised $460M in 2026

Portfolio highlights

  • Sharpa — Sharpa is an AI robotics company dedicated to developing ultra-high performance robots and core components. We Manufacture Time by Making Robots Useful.
  • Extreme shell technology — Extreme shell technology helps in creation and development of exoskeleton equipment for consumers. It uses data to drive exoskeleton innovation.
  • Reverse Matrix Technology — Reverse Matrix Technology focuses on the research and development of technologies that combine fundamental world models, enabling advanced simulations, intelligent systems, and data-driven insights to better understand complex environments and support next-generation innovation across industries.
Show all investments...

Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Medical Device startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Manufacturing
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 244
  • Round size: Angel $425k–$3.1M; Series A $1.5M–$60M; Series B $3M–$150M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely actively investing — fresh fund, raised $42M in 2025

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Sungen Biomedical — Sungen Biomedical is an innovative antibody drug R&D enterprise. It has established international standard technology platforms and original biological macromolecular R&D pipelines. Their focus includes therapeutic drugs for cardiovascular and cerebrovascular diseases, tumors, and more.
  • Chiplight Technology — Chipligh Technology develops optical interconnect and silicon photonics solutions for AI computing clusters.
Show all investments...

Medical Device VC funding in China at a glance

Stats across 1.4k deals from 1.6k investors.

1.6k
investors
in China Medical Device startups
1.4k
deals
in China Medical Device startups
$11M
median round
in China Medical Device startups
39%
lead investors
lead at least one round
28%
Series A
most common funding stage

Access all 1621 VC funds in China Medical Device startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device VC Funds in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 1621 VC funds investing in China Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists